iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile

Why is Microsoft laying off 3% of workforce? How will Trump’s tariff pause affect US businesses? What caused UnitedHealth CEO to step down abruptly? Why did Nissan announce major job cuts and plant closures? How did Coinbase's S&P 500 inclusion impact its stock? What’s behind Saudi Arabia’s $600 billion US investment? Why is Tesla stock surging despite softer China sales? How will Trump's drug price executive order affect pharma? What risks do US sanctions on Iran pose to oil prices?

iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile

benzinga.com/general/biotech/25/05/45384685/iteos-stock-soars-despite-trial-setback-on-liquidation-buzz-and-solid-cash-pile

iTeos Therapeutics, Inc. (NASDAQ:ITOS) reported topline results from an updated interim analysis of the GALAXIES Lung-201 Phase 2 study on Tuesday.
The trial sponsored by GSK Plc (NYSE:GSK) assessed the belrestotug + dostarlimab doublet in previously untreated, unresectable, locally…

This story appeared on benzinga.com, 2025-05-13 16:35:41.